Table 4.

Longitudinal changes in clinical parameters during the trial

Parameter	Time	Placebo (n = 18)		Ergocalciferol (n = 18)		P, from LSE estimates
		Mean	SD	Mean	SD
Systolic blood pressure, mm Hg	Baseline	104.9	9.1	106.4	10.6	.64
	Mo 3	105.0	10.5	105.0	9.1	.61
	Mo 6	108.8	9.9	107.4	13.8	.91
	Mo 9	110.1	11.5	109.3	13.9	.88
	Mo 12	109.1	10.4	107.3	12.6	.84
Diastolic blood pressure, mm Hg	Baseline	64.7	6.8	64.7	9.1	.98
	Mo 3	67.2	7.4	65.6	8.5	.84
	Mo 6	66.5	7.0	67.2	9.2	.62
	Mo 9	69.8	8.1	67.8	9.0	.71
	Mo 12	69.6	10.3	66.3	11.3	.49
Body mass index	Baseline	22.0	4.2	22.0	5.4	.99
	Month 3	22.2	4.7	22.1	6.1	.84
	Mo 6	22.3	4.4	22.1	6.1	.59
	Mo 9	21.9	4.5	22.1	6.2	.63
	Mo 12	22.0	4.8	22.6	6.0	.48
Body mass index, z score	Baseline	0.74	0.68	0.89	0.94	.58
	Mo 3	0.74	0.82	0.74	0.99	.68
	Mo 6	0.66	0.80	0.65	1.11	.71
	Mo 9	0.51	0.80	0.60	1.13	.69
	Mo 12	0.44	0.89	0.65	1.08	.32
Waist circumference, cm	Baseline	76.2	11.6	76.2	14.8	.96
	Mo 3	73.2	14.4	74.1	13.2	.54
	Mo 6	76.2	13.6	73.9	12.0	.88
	Mo 9	72.9	14.4	70.7	15.0	.85
	Mo 12	75.2	11.6	75.3	14.3	.80

Abbreviation: LSE, least square estimates, based on generalized linear model with repeated measures.